Advances in the Management of Medullary Thyroid Carcinoma: Focus on Peptide Receptor Radionuclide Therapy

Effective treatment options in advanced/progressive/metastatic medullary thyroid carcinoma (MTC) are currently limited. As in other neuroendocrine neoplasms (NENs), peptide receptor radionuclide therapy (PRRT) has been used as a therapeutic option in MTC. To date, however, there are no published rev...

Full description

Saved in:
Bibliographic Details
Published in:J Clin Med
Main Authors: Grossrubatscher, Erika, Fanciulli, Giuseppe, Pes, Luca, Sesti, Franz, Dolci, Carlotta, de Cicco, Federica, Colao, Annamaria, Faggiano, Antongiulio
Format: Artigo
Language:Inglês
Published: MDPI 2020
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7693147/
https://ncbi.nlm.nih.gov/pubmed/33138305
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9113507
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items